Willy Teng

Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate.

L. Jennings, D. Phillips, J. Jakubowski, 1997, Circulation.

Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function.

V. Wheaton, C. Turck, S. Coughlin, 1992, The Journal of biological chemistry.

Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide.

R. Scarborough, B. Blackhart, D. Oksenberg, 2000, Molecular pharmacology.

Ligand Cross-reactivity within the Protease-activated Receptor Family*

R. Scarborough, B. Blackhart, A. Martelli, 1996, The Journal of Biological Chemistry.

Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa.

D. Phillips, A. Arfsten, R. Scarborough, 1993, The Journal of biological chemistry.

Substituted acrylamides as factor Xa inhibitors: improving bioavailability by P1 modification.

B. Zhu, Yonghong Song, G. Park, 2002, Bioorganic & Medicinal Chemistry Letters.

Design, synthesis, and SAR of substituted acrylamides as factor Xa inhibitors.

J. Woolfrey, B. Zhu, Yonghong Song, 2002, Bioorganic & medicinal chemistry letters.

Design and synthesis of factor Xa inhibitors and their prodrugs.

B. Zhu, Yonghong Song, G. Park, 2003, Bioorganic & medicinal chemistry letters.